![REGENXBIO Inc. logo](/logos/RGNX.webp)
REGENXBIO Inc.
NASDAQ:RGNX
Overview | Financials
Company Name | REGENXBIO Inc. |
Symbol | RGNX |
Currency | USD |
Price | 11.48 |
Market Cap | 567,378,336 |
Dividend Yield | 0% |
52-week-range | 10.49 - 28.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Kenneth T. Mills |
Website | https://www.regenxbio.com |
An error occurred while fetching data.
About REGENXBIO Inc.
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD